Jefferies initiates coverage on Anthem Biosciences with a Rs 1,050 target
- Source
- The Economic Times - General
- Source link
- https://economictimes.indiatimes.com/markets/stocks/news/jefferies-initiates-coverage-on-anthem-biosciences-with-a-rs-1050-target/articleshow/133393891.cms
- Published
- 2026-08-21 05:19:56
- Discovered by ProcIntel
- 2026-08-21 09:23:01
- Category
- Procurement & Supply Chain News
- Geography
- India
- Organisations
- —
- Review status
- Pending
- Record type
- REAL
Summary
Jefferies has initiated coverage on Anthem Biosciences with a Buy rating and Rs 1,050 target, implying around 20% upside. The brokerage is bullish on the company’s integrated CRDMO model, strong return ratios and growth prospects, forecasting 18% revenue CAGR through FY29. Key triggers include new commercial molecules and biosimilar launches, while customer concentration and high capex remain key risks.
Procurement Relevance Gate
FAIL
— score 7.0/100 — evaluated 2026-08-21 09:23:01
Only geographic exposure matched — no substantive content indicator, so this cannot pass alone.
- geographic_exposure (weight 8) — matched on "1 linked geography"
Initial Signal Assessment ProcIntel's automatic, provisional read of this individual Signal -- Initial Significance and Initial Confidence, computed deterministically before any Event extraction or human review.
A provisional, automatically-computed reading of this individual Signal, before Event extraction or human review. Not a final rating.
Not Assessed — this Signal did not pass the Procurement Relevance Gate, or is fictional/excluded test data.